News

Microbio has appointed Paul Brennan as Chair of the Board, effective 2nd December 2024. Paul brings extensive global experience as a Non-Executive Director and biopharmaceutical industry leader. Currently, he serves as Non-Executive Chair of Immuron (ASX: IMC, NASDAQ IMRN), a biopharmaceutical company known for its gastrointestinal health product Travelan®, which is sold across Australia, Canada,… Continue reading Microbio Appoints Paul Brennan as Chair of the Board 

Microbio is pleased to announce the signing of a new distributor agreement with Iberlab, a trusted provider of advanced laboratory solutions, covering the territory of Portugal. This partnership marks a significant step in Microbio’s mission to expand the reach of its flagship test, InfectID™-BSI, which enables the rapid and accurate detection of pathogens causing bloodstream… Continue reading Microbio Expands European Footprint with New Distributor Agreement in Portugal

At Microbio, we’re proud to announce our latest step in global expansion – the signing of an exclusive distribution agreement with ELTA 90 MGR, a prominent distributor of advanced medical and laboratory diagnostics, to bring Microbio’s cutting-edge products to the Greek healthcare market. This strategic partnership is a key milestone in Microbio’s global expansion plan… Continue reading Microbio Expands into Greece with ELTA 90 MGR as Exclusive Distributor 

At Microbio, we’re excited to announce our latest milestone – the appointment of LionDx as our exclusive distributor in Italy. This partnership marks a significant step forward in expanding access to our innovative pathogen diagnostic solutions throughout Europe. Enhancing healthcare outcomes with InfectID-BSI™ Our flagship product, InfectID-BSI™, is at the core of this partnership. InfectID-BSI™… Continue reading Microbio Expands into Italy: LionDx Appointed as Exclusive Distributor